We Need Better Risk-Management-Strategy Communication

Ann Hale of Abbvie addresses the critical need for better communication with clinical trial sites about sponsor risk-management strategies. She discusses how sponsors need to explain their centralized monitoring approaches, anomaly detection methods, and what sites can expect in terms of queries and monitoring activities.